13 research outputs found

    ํ‰ํŒ ์ต๋‹จ ๊ฐ„๊ทน์˜ ๋ˆ„์„ค์œ ๋™์— ๊ด€ํ•œ ์‹คํ—˜์  ์—ฐ๊ตฌ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ธฐ๊ณ„ํ•ญ๊ณต๊ณตํ•™๋ถ€,2002.ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)-

    (A) study of the relationship between body image and depression in patients with vitiligo

    No full text
    ๋ณด๊ฑด๊ฐ„ํ˜ธํ•™๊ณผ/์„์‚ฌ[ํ•œ๊ธ€] ๋ณธ ์—ฐ๊ตฌ๋Š” ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์™€ ์ผ๋ฐ˜ํ”ผ๋ถ€์งˆํ™˜์ž, ๋ฐฑ๋ฐ˜์ค‘ ๋ฐœ์ƒ์ „ํŒŒ ํ›„, ๋ฐฑ๋ฐ˜์ฆ ์ดํ™˜๋ถ€์œ„๋ณ„ ์‹ ์ฒด ์ƒ์˜ ์šฐ์šธ์ •๋„๋ฅผ ํŒŒ์•…ํ•˜๊ณ , ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ๊ณผ ์šฐ์šธ๊ณผ์˜ ๊ด€๊ณ„๋ฅผ ๊ทœ๋ช…ํ•˜๊ธฐ ์œ„ํ•ด ์‹œ๋„ ๋œ ์ƒ๊ด€๊ด€๊ณ„ ๋ฐ ํ™˜์ž-๋Œ€์กฐ ์—ฐ๊ตฌ์ด๋‹ค. ์—ฐ๊ตฌ๋Œ€์ƒ์€ 1๊ฐœ ๋Œ€ํ•™๋ณ‘์› ํ”ผ๋ถ€๊ณผ์—์„œ ๋ฐฑ๋ฐ˜์ฆ๏ฟฝ 37๋ช…๊ณผ ์ผ๋ฐ˜ํ”ผ๋ถ€์งˆํ™˜์ž 37๋ช…์„ ํŽธ์˜์ถ”์ถœ ํ•˜์—ฌ 74๋ช…์„ ๋Œ€์ƒ์œผ๋กœ ํ•˜์˜€์œผ๋ฉฐ, ์กฐ์‚ฌ๊ธฐ๊ฐ„์€ 1989๋…„ 4์›” 17์ผ๋ถ€ํ„ฐ 5์›” 13์ผ๊นŒ์ง€์˜ 24์ผ๊ฐ„ ์ด์—ˆ๋‹ค. ์—ฐ๊ตฌ๋„๊ตฌ๋กœ๋Š” ์‹ ์ฒด์ƒ์„ ์ธก์ •ํ•˜๊ธฐ ์œ„ํ•ด ๋ฐ•์ •๋ชจ๊ฐ€ ๊ฐœ๋ฐœํ•œ ์‹ ์ฒด์˜๋ฏธ์ธก์ •๋„๊ตฌ๋ฅผ ์‚ฌ์šฉ ํ•˜์˜€์œผ๋ฉฐ, ์šฐ์šธ์„ ์ธก์ •ํ•˜๊ธฐ ์œ„ํ•ด์„œ๋Š” Beck์˜ Depression Inventory๋ฅผ ์‚ฌ์šฉํ•˜์˜€๋‹ค. ์ˆ˜์ง‘๋œ ์ž๋ฃŒ๋ฅผ ๋ถ„์„ํ•˜๊ธฐ ์œ„ํ•˜์—ฌ ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์™€ ์ผ๋ฐ˜ํ”ผ๋ถ€์งˆํ™˜์ž์˜ ์ผ๋ฐ˜์ ์ธ ํŠน์„ฑ์€ ์‹ค์ˆ˜ ์™€ ๋ฐฑ๋ถ„์œจ, X^^2-test๋ฅผ ์‚ฌ์šฉํ•˜์˜€๊ณ , ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์™€ ์ผ๋ฐ˜ํ”ผ๋ถ€์งˆํ™˜์ž์˜ ์‹ ์ฒด์ƒ๊ณผ ์šฐ์šธ์ •๋„, ๋ฐฑ๋ฐ˜์ฆ ๋ฐœ์ƒ์ „ยทํ›„์™€ ์ดํ™˜๋ถ€์œ„๋ณ„ ์‹ ์ฒด์ƒ์€ t - test๋ฅผ, ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ๊ณผ ์šฐ์šธ์ •๋„ ์™€์˜ ์ƒ๊ด€๊ด€๊ณ„์— ๋Œ€ํ•œ ๊ฐ€์„ค๊ฒ€์ •์€ Pearson's product correlation coefficient๋ฅผ ์‚ฌ์šฉํ•˜ ์˜€๋‹ค. ๋Œ€์ƒ์ž์˜ ์‹ ์ฒด์ƒ๊ณผ ์šฐ์šธ์ •๋„๋Š” ํ‰๊ท ์ ์ˆ˜์™€ ํ‘œ์ค€ํŽธ์ฐจ, ์ตœ๋Œ€๊ฐ’, ์ตœ์†Œ๊ฐ’์„ ๊ตฌํ•˜์˜€๊ณ , ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ ๋ฐ ์šฐ์šธ์ •๋„์™€ ์ผ๋ฐ˜์  ํŠน์„ฑ๊ณผ์˜ ๊ด€๊ณ„๋Š” t - test, ANOVA๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„์„ํ•˜์˜€๋‹ค. ๋ณธ ์—ฐ๊ตฌ์˜ ๊ฒฐ๊ณผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค. 1. ์ œ1๊ฐ€์„ค, "๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ์ด ์ผ๋ฐ˜ํ”ผ๋ถ€์งˆํ™˜์ž์˜ ์‹ ์ฒด์ƒ๋ณด๋‹ค ๋‚ฎ์„ ๊ฒƒ์ด๋‹ค."๋Š” ์ง€์ง€๋˜์—ˆ๋‹ค(t=6.36, P<0.01). 2. ์ œ2๊ฐ€์„ค, "๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์šฐ์šธ์ •๋„๊ฐ€ ์ผ๋ฐ˜ํ”ผ๋ถ€์งˆํ™˜์ž์˜ ์šฐ์šธ์ •๋„๋ณด๋‹ค ๋†’์„ ๊ฒƒ์ด๋‹ค. "๋Š” ์ง€์ง€๋˜์—ˆ๋‹ค(t=5.97, P<0.01). 3. ์ œ3๊ฐ€์„ค, "๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ์ด ๋‚ฎ์„์ˆ˜๋ก ์šฐ์šธ์ •๋„๋Š” ๋†’์„ ๊ฒƒ์ด๋‹ค."๋Š” ๊ธฐ๊ฐ๋˜์—ˆ ๋‹ค(r=-.2244, p>0.05). 4. ์ œ4๊ฐ€์„ค, "๋ฐฑ๋ฐ˜์ฆ ๋ฐœ์ƒ์ด์ „์˜ ์‹ ์ฒด์ƒ๋ณด๋‹ค ๋ฐฑ๋ฐ˜์ฆ ๋ฐœ์ƒ์ดํ›„์˜ ์‹ ์ฒด์ƒ์ด ๋” ๋‚ฎ์„ ๊ฒƒ ์ด๋‹ค."๋Š” ์ง€์ง€๋˜์—ˆ๋‹ค(t=5.51, P<0.01). 5. ์ œ5๊ฐ€์„ค, "๋…ธ์ถœ๋ถ€์œ„์— ์ดํ™˜๋œ ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ์ด ๋น„๋…ธ์ถœ๋ถ€์œ„์— ์ดํ™˜ ๋œ ๋ฐฑ๋ฐ˜ ์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ๋ณด๋‹ค ๋‚ฎ์„ ๊ฒƒ์ด๋‹ค."๋Š” ์ง€์ง€๋˜์—ˆ๋‹ค((t=4.22, P<0.01). 6. ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์ผ๋ฐ˜์  ํŠน์„ฑ๊ณผ ์‹ ์ฒด์ƒ๊ณผ์˜ ๊ด€๊ณ„์—์„œ๋Š” ์„ฑ๋ณ„, ์—ฐ๋ น, ๊ฒฐํ˜ผ์ƒํƒœ, ์ข…๊ต, ํ•™๋ ฅ, ๊ฒฝ์ œ์ƒํƒœ, ๋ฐฑ๋ฐ˜์ฆ ์ดํ™˜๊ธฐ๊ฐ„๋ณ„๋กœ ์œ ์˜ํ•œ ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค. 7. ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์ผ๋ฐ˜์  ํŠน์„ฑ๊ณผ ์šฐ์šธ์ •๋„์™€์˜ ๊ด€๊ณ„์—์„œ๋Š” ์„ฑ๋ณ„์—์„œ๋งŒ ์œ ์˜ํ•œ ์ฐจ์ด๊ฐ€ ์žˆ์—ˆ์œผ๋ฉฐ, ์—ฐ๋ น, ๊ฒฐํ˜ผ์ƒํƒœ, ์ข…๊ต, ํ•™๋ ฅ, ๊ฒ…์ œ์ƒํƒœ, ๋ฐฑ๋ฐ˜์ฆ ์ดํ™˜๊ธฐ๊ฐ„๋ณ„๋กœ๋Š” ์œ ์˜ํ•œ ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค. ์ด ์—ฐ๊ตฌ์˜ ๊ฒฐ๊ณผ๋ฅผ ์ข…ํ•ฉํ•ด ๋ณผ ๋•Œ, ๋ฐฑ๋ฐ˜์ฆํ™˜์ž๋Š” ์ผ๋ฐ˜ํ”ผ๋ถ€์งˆํ™˜์ž๋ณด๋‹ค ์‹ ์ฒด์ƒ์ด ๋‚ฎ๊ณ  ์šฐ ์šธ์ •๋„๊ฐ€ ๋†’์•˜์œผ๋ฉฐ, ๋ฐฑ๋ฐ˜์ฆ ๋ฐœ์ƒ์ด์ „๋ณด๋‹ค ๋ฐœ์ƒ์ดํ›„์˜ ์‹ ์ฒด์ƒ์ด ๋‚ฎ๊ณ , ๋น„๋…ธ์ถœ๋ถ€์œ„๋ณด๋‹ค ๋…ธ ์ถœ๋ถ€์œ„์— ์ดํ™˜๋œ ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ์ด ๋” ๋‚ฎ์•˜์œผ๋‚˜, ๋ฐฑ๋ฐ˜์ฆํ™˜์ž์˜ ์‹ ์ฒด์ƒ๊ณผ ์šฐ์šธ์ •๋„๋Š” ๊ด€๋ จ์„ฑ์ด ์—†์—ˆ๋‹ค. [์˜๋ฌธ] This correlational and case-control study was undertaken in order to examine if there was a difference in body image and depression between patients with vitiligo and patients with mild skin disorders, between patients with vitiligo before onset and after inset, between patients with vitiligo on body site that is visible and on a body site that is non-visible, and if there was a relationship between body image and depression in patients with vitiligo. Thirty seven patients with vitiligo and 37 patients with mild skin disorders were selected from the skin department of one university hospital for this study. The sampling used was a non-probability, convenient sampling technique. Data were collected by means of a questionnaire and the study was carried out from April 17 to May 13, 1989. The instruments used for this study were the Body Meaning Scale developed by Park and the Beck Depression Inventory by Beck. Analysis for data was done using percentages, frequencies, means, standard deviations, Pearson's product correlation coefficient, X^^2-test, t-test and ANOVA. The findings of this study were as follows: 1. The first hypothesis,"The body image score for patients with vitiligo will be lower than for those with mild skin disorder." was supported (t=6.36, p<0.01). 2. The second hypothesis, "The depression level for patients with vitiligo will be higher than for those with mild skin disorders."was supported(t=5.97, p<0.01). 3. The third hypothesis, "The lower the body image score, the higher the depression level for patients with vitiligo." was rejected(r= -.2244, P > 0.05). 4. The fourth hypothesis, "The body image score for after onset of vitiligo will be lower than for before onset."was supported(t=5.51, p<0.01). 5. The fifth hypothesis, "The body image score for vitiligo on visible body sites will be lower than for non-visible body sites." was supported(t=4.22, p<0.01). 6. There was no significant difference between demographic factors and the body image score in patients with vitiligo. 7. There was no significant difference between demographic factors except sex and the depression level in patients with vitiligo. In conclusion, the body image score for patients with vitiligo was lower than for those with mild skin disorders, the depression level for patients with vitiligo was higher than for those with mild skin disorders, and the body image score for after onset or for visible body sites for vitiligo was lower than for before onset or for non-visible sites. There was no relationship between body image and depression in patients with vitiligo.restrictio

    Scaffold์ƒ์— ์‹๋ฆฝํ•œ ์‚ฌ๋žŒ์น˜์ฃผ์ธ๋Œ€์„ฌ์œ ๋ชจ์„ธํฌ๋ฅผ ํ†ตํ•œ ์น˜์ฃผ์กฐ์ง๊ณตํ•™

    No full text
    Human periodontal ligament fibroblasts (hPDLF) are very important for curing the periodontal tissue because they can be differentiated into various cells. A tissue engineering approach using a cell-scaffold is essential for comprehending today's periodontal tissue regeneration procedure. This study examined the possibility of using an acellular dermal matrix as a scaffold for human periodontalligament fibroblast (hPDLF). The hPDLF was isolated from the middle third of the root of periodontally healthy teeth extracted for orthodontic reasons. The cells were cultured in a medium containing Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum at in humidified air with 5% . The acellular dermal matrix(ADM) was provided by the US tissue banks(USA). Second passage cells were used in this study. The hPDLF cells were cultured with the acellular dermal matrix for 2 days, and the dermal matrix cultured by the hPDLF was transferred to a new petri dish and used as the experimental group. The control group was cultured without the acellular dermal matrix, The control and experimental cells were cultured for six weeks. The hPDLF cultured on the acellular dermal matrix was observed by Transmission Electron microscopy (TEM). Electron micrography shows that the hPDLF was proliferated on the acellular dermal matrix. This study suggests that the acellular dermal matrix can be used as a scaffold for hPDLF.์ด ๋…ผ๋ฌธ์€ 2005๋…„ ์ •๋ถ€(๊ต์œก์ธ์ ์ž์›๋ถ€)์˜ ์žฌ์›์œผ๋กœ ํ•œ๊ตญํ•™์ˆ ์ง„ํฅ์žฌ๋‹จ์˜ ์ง€์›์„ ๋ฐ›์•„ ์ˆ˜ํ–‰๋œ ์—ฐ๊ตฌ์ž…๋‹ˆ๋‹ค
    corecore